Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Cellectar Biosciences Inc...

    NASDAQ: CLRB · Real-Time Price · USD
    4.37
    -0.05 (-1.13%)
    At close: Aug 15, 2025, 3:59 PM
    4.41
    0.92%
    After-hours: Aug 15, 2025, 07:05 PM EDT

    Cellectar Biosciences Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 23.29M 9.56M 19.87M 35.7M
    Short-Term Investments
    		 n/a n/a n/a n/a
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 29.78K 29.78K 81.21K 81.21K
    Receivables
    		 n/a n/a n/a n/a
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 961.66K 888.23K 663.24K n/a
    Total Current Assets
    		 24.25M 10.45M 20.53M 36.57M
    Property-Plant & Equipment
    		 1.19M 1.59M 978.98K 549.13K
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 1.22M 1.62M 1.06M 630.35K
    Total Assets
    		 25.47M 12.08M 21.59M 37.2M
    Account Payables
    		 611K 5.62M 2.56M 1.42M
    Deferred Revenue
    		 n/a n/a n/a 2.44M
    Short-Term Debt
    		 84.42K n/a n/a 135.45K
    Other Current Liabilities
    		 8.61M 18.19M 2M -639.53K
    Total Current Liabilities
    		 9.39M 25.36M 5.53M 3.99M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 1.38M n/a n/a n/a
    Total Long-Term Liabilities
    		 1.79M 494K 552.98K 166.29K
    Total Liabilities
    		 11.18M 25.85M 6.08M 4.16M
    Total Debt
    		 494K 552.98K 603.83K 301.74K
    Common Stock
    		 461.00 207.00 94.00 611.00
    Retained Earnings
    		 -247.34M -217.48M -179.5M -150.9M
    Comprehensive Income
    		 n/a n/a n/a n/a
    Shareholders Equity
    		 14.29M -15.16M 15.51M 33.05M
    Total Investments
    		 n/a n/a n/a n/a

    Add to Watchlist